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ABSTRACT 
Pyrimidine-2-thiol (1) has been synthesized via one-pot, three component synthesis. Its behavior towards nitrogen 
nucleophiles like hydrazine hydrate, ethylamine, piperidine, and 2-aminobenzoic acid has been studied. A speculation to 
explain the activities of the thioamide-iminothiol equilibrium based on their thermodynamic and kinetic control under the 
experimental conditions were investigated. The hydrazinopyrimidine 2 and aminocarbamoyl derivative 8 were used as key 
starting materials for synthesis of some interesting nitrogen bridgehead compounds 10-13, hydrazones 14-16, and some 
mixed and non-mixed heterocyclic systems 17-19 respectively. 
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INTRODUCTION  
In 1893 Italian Chemist Pietro Biginelli reported on the acid-catalysed cyclocondensation reaction of ethyl acetoacetate, 
benzaldehyde, and urea [1]. The reaction was carried out simply by heating a mixture of the three components dissolved 
in EtOH with a catalytic amont of HCl at refluxing temperature. The product of  this novel one-pot, three-component 
synthesis that precipitated on cooling of the reaction mixture was identified correctly by Biginelli as 3,4-dihydropyrimidin-
2(1H)-one. The synethetic potential of this new heterocycle synthesis (now known as Biginelli reaction) remained 
unexplored for quite some time.  
In the 1970s and 1980s interest slowly increased, and the scope of the original cyclocondensation reaction was gradually 
extended by variation of all three builiding blocks, allowing access to a large number of multifunctionallized 
dihydropyrimidines [2,3]. Since that late 1980s, a tremendous increase in activity has again occurred, as evidenced by the 
growing number of publications and patents on that subject [3,4]. This is mainly due to the fact that the multifunctionallized 
dihydropyrimidine “DHPMs“ represents a heterocyclic system of remarkable pharmacological efficiency. In the past 
decades, a broad range of biological effects including antiviral, antitumor, antibacterial, and anti-inflammatory activities has 
been ascribed to these partialy reduced pyrimidine derivatives [5-13]. More recently, DHPMs have emerged as for 
example, orally active antihypertensive agents [14-18].  
A very recent highlight in this context has been identified structurally rather simple DHPM monastrol as a mitotic Kinesin 
motor protein inhibitor and potential new lead for the development of anticancer drug  [19]. Appropriately functionalized 
DHPMs have emerged as potent calcium channel blockers [20-21]. A part from synthetic DHPM derivatives, several 
marine natural products with interesting biological activities containing the dihydropyrimidine-5-carboxylate core have 
recently been isolated [22]. Most notably among these are the batzelladine alkaloids A and B which inhibit the binding of 
HIV envelope protein gp-120 to human CD4 cells and therefore, are potential new leads for AIDS therapy [23]. 
Herein, we report the synthesis of a thioxopyrimidine derivative 1 and its uses as key starting material for synthesis of 
some interesting heterocycles. 
EXPERIMENTAL 
General procedure 
Reagents and solvents were used as obtained from the supplier without further purification. All melting points reported are 
uncorrected and were determined on a Stuart electric melting point apparatus. Elemental analysis were carried out in the 
Micro Analytical Center, Cairo University, Giza, Egypt. Thin-layer chromatography (TLC) was performed on Merk TLC 
aluminium sheets silica gel 60 F254 with detection by UV quenching at 254nm. IR spectra (in KBr, cm
-1
) were recorded on 
FTIR 8201PC Shimadzu (Japan, 1995). 
1
H NMR spectra were recorded on a Varian 300 MHz (Germany, 1999) with 
residual proton signal of the deuterated solvent as the internal reference (H=7.26 ppm for CDCl3 and H=2.51 ppm for 
DMSO-d6). TMS was used as an internal standard with chemical shifts  in ppm from downfield to upfield. EIMS were 
recorded on a gas chromatographic GCMS –Qploopx Shimadzu (Japan, 1990). 
4-(3,4-Dichlorophenyl)-6-(furan-2-yl)pyrimidine-2-thiol (1)  
A mixture of 3,4-dichloroacetophenone (1.89 g, 0.01 mol), furfural (0.96 g, 0.01 mol), and thiourea (0.76 g, 0.01 mol) and 
CH3ONa (0.01 mol) in 30 mL EtOH was heated under reflux in an oil bath for 7h. The reaction mixture was cooled and the 
solid that obtained was filtered off, the filtrate was neutralized with AcOH. The product that obtained was recrystallized 
from PhCH3 to give 1. Yield 56%; mp 161-162 °C; IR (KBr, cm
-1
): 1451 (C=S), 3059 (CH-arom.); 
1
H-NMR (300 MHz, 
DMSO-d6, δ / ppm): 3.82 (s, 1H, SH), 6.58 (dd, J1=1.7Hz, J2=3.6Hz, 1H, furyl-H), 7.11-7.18 (m, 3H, pyrimidine-H & Ar-H & 
furyl-H), 7.57-7.61 (m, 2H, Ar-H & furyl-H), 7.89 (d, J=8.17Hz, 1H, Ar-H). Anal. Calcd. for C14H8Cl2N2OS (323.20): C, 
52.03;  H, 2.49; Cl, 21.94; N, 8.67; S, 9.92. Found: C, 52.33; H, 2.56; Cl, 22.36; N, 8.91; S, 9.70. MS: m/z  323[M]
+
, 
325[M
+
+2], and 327[M
+
+4]. 
4-(3,4-Dichlorophenyl)-6-(furan-2-yl)-2-hydrazinylpyrimidine (2)  
A solution of thioxopyrimidine 1 (3.23 g, 0.01 mol) and hydrazine hydrate (0.75 g, 0.015ml) in 20 mL EtOH was heated 
under reflux for 6h. The solid that formed after concentration and cooling was filtered off and crystallized from PhH to give 
2. Yield 74%; mp 129-131 °C; IR (KBr, cm
-1
): 3071 (CH-arom.), 3190, 3327 (NH); 
1
H-NMR (300 MHz, DMSO-d6, δ / ppm): 
4.86 (brs, 1H, NH), 6.49 (dd, J1=1.7Hz, J2=3.6Hz, 1H, furyl-H), 7.08 (s, 1H, pyrimidine-H), 7.17-7.24 (m, 2H, Ar-H & furyl-
H), 7.49-7.67 (m, 2H, Ar-H & furyl-H), 7.78 (d, J=8.2Hz, 1H, Ar-H). Anal. Calcd. for C14H10Cl2N4O (321.17): C, 52.36; H, 
3.14; Cl, 22.08; N, 17.45. Found: C, 52.62; H, 3.29; Cl, 21.87; N, 17.22. MS: m/z  321[M]
+
, 323[M
+
+2], 325[M
+
+4]. 
4-(3,4-Dichlorophenyl)-N-ethyl-6-(furan-2-yl)pyrimidin-2-amine (3)  
A mixture of thioxopyrimidine 1 (3.23 g, 0.01 mol) and C2H5NH2 (0.45 g, 0.01 ml) in 20 mL EtOH was heated under reflux 
for 6h. The solid that formed after concentration and cooling was filtered off and crystallized from PhH to give 3. Yield 
77%; mp 142-143 °C; IR (KBr, cm
-1
): 2928 (CH-aliph.), 3064 (CH-arom.), 3176 (NH); 
1
H-NMR (300 MHz, DMSO-d6, δ / 
ppm): 1.17 (t, J=7.1Hz, 3H, CH3), 3.24 (q, J=7.1Hz, 2H, CH2), 5.82 (brs, 1H, NH), 6.56 (dd, J1=1.7Hz, J2=3.6Hz, 1H, furyl-
H), 7.06-7.14 (m, 2H, Ar-H & pyrimidine-H), 7.39-7.61 (m, 3H, Ar-H & furyl-H), 7.83 (d, 1H, J=8.1Hz, Ar-H). Anal. Calcd. 
for   C16H13Cl2N3O (334.20): C, 57.50; H, 3.92; Cl, 21.22; N, 12.57. Found: C, 57.74; H, 4.15; Cl, 21.03; N, 12.88. 
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4-(3,4-Dichlorophenyl)-6-(furan-2-yl)-2-(piperidin-1-yl)pyrimidine (4)  
A mixture of thioxopyrimidine 1 (3.23 g, 0.01 mol) and piperidine (0.85 g, 0.01 mol) in 15 mL MeOH was refluxed for 6h. 
The solid that formed after concentration and cooling was filtered off and crystallized from AcOH to give 4. Yield 65%; mp 
175 °C; IR (KBr, cm
-1
): 2941 (CH-aliph.), 3059 (CH-arom.). Anal. Calcd. for C19H17Cl2N3O (374.26): C, 60.97; H, 4.58; Cl, 
18.95; N, 11.23. Found: C, 61.19; H, 4.35; Cl, 19.33; N, 11.62. MS: m/z  375[M]
+
, 377[M
+
+2]. 
2-(3,4-Dichlorophenyl)-4-(furan-2-yl)-6H-pyrimido[2,1-b]quinazolin-6-one (5)  
An equimolar amounts of thioxopyrimidine 1 (3.23 g, 0.01 mol) and 2-aminobenzoic acid (0.01mol) in 1,4-dioxane (30mL) 
was heated under reflux at 100C for 2h. The reaction mixture was cooled down and a few drops of concentrated H2SO4 
was added with stirring at r. t and stirring was continued for 2h. Then the reaction mixture was poured over ice water and 
the solid that formed was collected and recrystallized from PhH to give 5. Yield 53%; mp 120-122 °C; IR (KBr, cm
-1
): 1676 
(CO), 3063 (CH-arom.); 
1
H-NMR (300 MHz, DMSO-d6, δ / ppm): 6.64-6.77 (m, 2H, furyl-H), 7.43-7.56 (m, 4H, Ar-H & 
furyl-H & pyrimidine-H), 7.60-7.78 (m, 3H, Ar-H), 8.27-8.51 (m, 2H, Ar-H). Anal. Calcd. for C21H11Cl2N3O2 (408.24): C, 
61.78; H, 2.72; Cl, 17.37; N, 10.29. Found: C, 62.14; H, 2.95; Cl, 17.12; N, 10.55. 
{[4-(3,4-Dichlorophenyl)-6-(furan-2-yl)pyrimidin-2-yl]sulfanyl}acetic acid (6)  
A mixture of compound 1 (3.23 g, 0.01 mol) and chloroacetic acid (0.95 g, 0.01mol), alcoholic NaOH (2 mL, 10%) in 30 mL 
EtOH was heated under reflux for 3h. The excess solvent was distiled off and the residue was poured up on water, 
neutralized with dil. HCl. The solid that formed was washed with H2O, filtered off and crystallized from AcOH to give 6. 
Yield 59%; mp 192-193 °C; IR (KBr, cm
-1
): 1154 (C-S), 1710 (CO), 3063 (CH-arom.), 3426 (OH). Anal. Calcd. for 
C16H10Cl2N2O3S (381.23): C, 50.41; H, 2.64; Cl, 18.60; N, 7.35; S, 8.41. Found: C, 50.76; H, 2.85; Cl, 18.83; N, 7.63; S, 
8.17.  
Ethyl {[4-(3,4-dichlorophenyl)-6-(furan-2-yl)pyrimidin-2-yl]sulfanyl} acetate (7) 
A mixture of compound 1 (3.23 g, 0.01 mol) and ethyl chloroacetate (3.69 g, 0.03 mol) in dry pyridine (20 mL) was heated 
under reflux for 4h. The reaction mixture after cooling was poured over HCl/crushed ice. The solid obtained was filtered off 
and crystallized from AcOH to give 7. Yield 71%; mp 137-139 °C; IR (KBr, cm
-1
): 1152(C-S), 1745 (CO), 3070 (CH-arom.);
 
1
H-NMR (300 MHz, DMSO-d6, δ / ppm): 1.08 (t, J=6.9Hz, 3H, CH3), 3.29 (s, 2H, CH2), 3.93 (q, J=7.9Hz, 2H, CH2), 6.53 
(dd, J1=1.7Hz, J2=3.6Hz, 1H, furyl-H), 7.18-7.23 (m, 3H, Ar-H & pyrimidine-H& furyl-H), 7.59-7.64 (m, 2H, Ar-H & furyl-H), 
7.88 (d, 1H, J=8.2Hz, Ar-H). Anal. Calcd. for C18H14Cl2N2O3S (409.29): C, 52.82; H, 3.45; Cl, 17.32; N, 6.84; S, 7.83. 
Found: C, 53.10; H, 3.58; Cl, 17.11; N, 7.18; S, 7.65. 
2-{[4-(3,4-Dichlorophenyl)-6-(furan-2-yl)pyrimidin-2-yl]sulfanyl} acetohydrazide (8)  
A solution of thioxopyrimidine 7 (4.09 g, 0.01 mol) and hydrazine hydrate (0.75 g, 0.015 mol) in 20 mL EtOH was heated 
under reflux for 8h. The solid that formed after concentration and cooling was filtered off and crystallized from EtOH to give 
8. Yield 54%; mp 171 °C; IR (KBr, cm
-1
): 1681 (CO), 2923 (CH-aliph.), 3151, 3390  (NH). Anal. Calcd. for C16H12Cl2N4O2S 
(395.26): C, 48.62; H, 3.06; Cl, 17.94; N, 14.17; S, 8.11. Found: C, 48.94; H, 3.39; Cl, 18.26; N, 14.47; S, 8.32. 
Formation of 9a,b  
An equimolar mixture of compound 1 and 3-[(4-bromobenzoyl) and/or 2-furyl]prop-2-enoic acid (0.01 mol), and few drops 
of piperidine in 30 mL dry benzene was heated at 80C in water bath for 3h. The excess solvent removed by steam 
distillation and the crude obtained was purified by recrystallization from PhCH3 to give 9a and 9b respectively. 
5-(4-Bromo-phenyl)-2-[4-(3,4-dichloro-phenyl)-6-furan-2-yl-pyrimidin-2-ylsulfanyl]-5-
oxo-pentanoic acid (9a): Yield 62 %; mp 220-222 °C; IR (KBr, cm-1): 1710 (CO), 2938 (CH-aliph.), 3135, 3300 
(OH); 
1
H-NMR (300 MHz, DMSO-d6, δ / ppm): 2.39-2.43 (m, 2H, CH2), 3.12 (t, J=7.1Hz, 2H, CH2), 4.26 (t, J=7.8Hz, 1H, 
CH), 6.57 (dd, J1=1.7Hz, J2=3.6Hz, 1H, furyl-H), 7.16-7.23 (m, 3H, Ar-H & pyrimidine-H& furyl-H), 7.60-7.82 (m, 7H, Ar-H 
& furyl-H), 10.42 (brs, 1H, OH). Anal. Calcd. for C25H17BrCl2N2O4S (592.29): C, 50.70; H, 2.89; Cl, 11.97; N, 4.73; S, 5.41. 
Found: C, 50.97; H, 3.05; Cl, 11.64; N, 4.92; S, 5.66. 
2-{[4-(3,4-Dichlorophenyl)-6-(furan-2-yl)pyrimidin-2-yl]sulfanyl}-5-(furan-2-yl)-5-
oxopentanoic acid (9b): Yield 69%; mp 237-239 °C; IR (KBr, cm-1): 1709, 1715 (CO), 2936 (CH-aliph.), 3345 
(OH). Anal. Calcd. for C23H16Cl2N2O5S (503.36): C, 54.88; H, 3.20; Cl, 14.09; N, 5.57; S, 6.37. Found: C, 55.21; H, 3.43; 
Cl, 13.91; N, 5.81; S, 6.55. 
7-(3,4-Dichlorophenyl)-5-(furan-2-yl)[1,2,4]triazolo[4,3-a]pyrimidine (10) 
A solution of compound 2 (3.21 g, 0.01 mol) in 10 mL freshly distilled Ac2O was heated under reflux for 1.5h. The solid that 
formed after concentration and cooling was filtered off and crystallized from EtOH to give 10. Yield 76%; mp 164-165 °C; 
IR (KBr, cm
-1
): 2955 (CH-aliph.), 3068 (CH-arom.); 
1
H-NMR (300 MHz, DMSO-d6, δ / ppm): 6.68 (dd, J1=1.7Hz, J2=3.6Hz, 
1H, furyl-H), 7.13 (s, 1H, pyrimidine-H), 7.36 (d, J=8.7Hz, 1H, Ar-H), 7.83-8.03 (m, 4H, Ar-H & furyl-H), 8.78 (s, 1H, 
triazole-H). Anal. Calcd. for C15H8Cl2N4O (331.16): C, 54.40; H, 2.43; Cl, 21.41; N, 16.92. Found: C, 54.69; H, 2.62; Cl, 
21.17; N, 17.19. 
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7-(3,4-Dichlorophenyl)-5-(furan-2-yl)[1,2,4]triazolo[4,3-a]pyrimidine-3(2H)-thione (11)  
To a solution of  2 (3.21 g, 0.01 mol) in dry pyridine (30 mL), CS2 (1.52 g, 0.02 mol) was added and the reaction mixture 
was heated under reflux for 8h. After cooling the reaction mixture was poured onto ice/HCl mixture and the solid that 
separated was washed with cold water, filtered off, and crystallized from EtOH to give 11. Yield 61%; mp 198 °C; IR (KBr, 
cm
-1
): 1453 (C=S), 2977 (CH-aliph.), 3400 (NH). Anal. Calcd. for C15H8Cl2N4OS (363.22): C, 49.60; H, 2.22; Cl, 19.52; N, 
15.43; S, 8.83. Found: C, 49.24; H, 2.38; Cl, 19.20; N, 15.74; S, 9.12. MS: m/z  363[M]
+
, 365[M
+
+2], 367[M
+
+4]. 
2-{[4-(3,4-Dichlorophenyl)-6-(furan-2-yl)pyrimidin-2-yl]amino}-1H-isoindole-1,3(2H)-
dione (12) 
To a solution of 2 (3.21 g, 0.01 mol) in n-BuOH, 0.01 mol of phathalic acid anhydride was added. The reaction mixture was 
leaved overnight and the solid that formed was collected and crystallized from EtOAc to give 12. Yield 56%; mp 149-150 
°C; IR (KBr, cm
-1
): 1685, 1737 (CO), 3118 (NH); 
1
H-NMR (300 MHz, DMSO-d6, δ / ppm): 6.44 (d, J=3.6Hz, 1H, furyl-H), 
6.61 (dd, J1=1.7Hz, J2=3.6Hz, 1H, furyl-H), 7.14-7.20 (m, 2H, Ar-H & pyrimidine-H), 7.54-7.81 (m, 3H, Ar-H & furyl-H), 
7.93-8.04 (m, 4H, Ar-H), 8.24 (brs, 1H, NH). Anal. Calcd. for C22H12Cl2N4O3 (451.26): C, 58.55; H, 2.68; Cl, 15.71; N, 
12.42. Found: C, 58.85; H, 2.86; Cl, 15.90; N, 12.75. 
4-(3,4-Dichlorophenyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)-6-(furan-2-yl)pyrimidine (13)  
A mixture of 2 (3.21 g, 0.01 mol),  acetyl acetone (0.54 g, 0.01 mol), and few drops of piperidine in 30 mL EtOH was 
heated at 70C for 5h. The solid that separated after concentration and cooling was filtered off and recrystallized from light 
pet. ether (80-100) to give 13. Yield 49%; mp 138-140 °C; IR (KBr, cm
-1
): 1610 (C=N), 2911 (CH-aliph.), 3048 (CH-
arom.). Anal. Calcd. for  C19H14Cl2N4O (385.25): C, 59.24; H, 3.66; Cl, 18.41; N, 14.54. Found: C, 59.03; H, 3.79; Cl, 
17.94; N, 14.82. MS: m/z  385[M]
+
, 387[M
+
+2]. 
4-[{2-[4-(3,4-Dichlorophenyl)-6-(furan-2-yl)pyrimidin-2-yl] 
hydrazinylidene}methyl]phenol (14)  
A mixture of 2 (3.21 g, 0.01 mol), 4-hydroxybenzaldehyde (1.22 g, 0.01 mol), in 1,4-dioxane (20 mL) was refluxed for 5h. 
The solid that separated after concentration and cooling was recrystallized from EtOH to give 14. Yield 82%; mp 176-177 
°C; IR (KBr, cm
-1
): 1600 (C=N), 3290 (NH), 3480 (OH); 
1
H-NMR (300 MHz, DMSO-d6, δ / ppm): 6.67-6.69 (m, 4H, Ar-H & 
=CH & furyl-H), 6.84-6.87 (m, 5H, Ar-H & furyl-H & pyrimidine-H), 8.30-8.54 (m, 3H, ArH), 10.03 (brs, 1H, NH, D2O 
exchangable), 10.09 (brs, 1H, OH, D2O exchangable). Anal. Calcd. for C21H14Cl2N4O2 (425.27): C, 59.31; H, 3.32; Cl, 
16.67; N, 13.17. Found: C, 59.04; H, 3.14; Cl, 16.21; N, 13.38. MS: m/z  425[M]
+
. 
2-[4-(3,4-Dichlorophenyl)-6-(furan-2-yl)pyrimidin-2-yl]-N-phenylhydrazine 
carboxamide (15)  
A mixture of compound 2 (3.21 g, 0.01 mol), phenyl isocyanate (0.01 mol) and a catalytic amount of Et3NH2 in MeOH (20 
mL) was refluxed for 7 h. The reaction mixture was concentrated and the precipitate formed was filtered off and 
recrystallized from PhH to give 15. Yield 73%; mp 112-114 °C; IR (KBr, cm
-1
): 1605 (C=N), 1709 (CO), 3136, 3300 (NH); 
1
H-NMR (300 MHz, CDCl3, δ / ppm): 6.95-6.99 (m, 3H, Ar-H & furyl-H), 7.24-7.29 (m, 5H, Ar-H & furyl-H), 7.47-7.50 (m, 
4H, Ar-H & pyrimidine-H), 9.64 (brs, 3H, 3NH, D2O exchangable). Anal. Calcd. for C21H15Cl2N5O2 (440.28): C, 57.29; H, 
3.43; Cl, 16.10; N, 15.91. Found: C, 57.08; H, 3.25; Cl, 16.43; N, 16.22. 
N'-[(4-Chlorophenyl)methylidene]-2-{[4-(3,4-dichlorophenyl)-6-(furan-2-yl)pyrimidin-2-
yl]sulfanyl}acetohydrazide (16) 
An equimolar ratio of 2 (3.21 g, 0.01 mol), 4-chlorobenzaldehyde (1.41 g, 0.01 mol), in EtOH (20 mL) was refluxed for 6h. 
The solid that separated after concentration and cooling was recrystallized from EtOH to give 16. Yield 77%; mp 211-213 
°C; IR (KBr, cm
-1
): 1682 (CO), 2934 (CH-aliph.), 3300 (NH). Anal. Calcd. for C23H15Cl3N4O2S (517.82): C, 53.35; H, 2.92; 
Cl, 20.54; N, 10.82; S, 6.19. Found: C, 53.67; H, 2.75; Cl, 20.28; N, 11.16; S, 6.53. MS: m/z  518[M]
+
. 
4-(3,4-Dichloro-phenyl)-6-furan-2-yl-2-(5-p-tolyl-2,3-dihydro-[1,3,4]oxadiazol-2-yl 
methylsulfanyl)-pyrimidine (17)  
To a mixture of 8 (3.95 g, 0.01 mol) and P-toluic acid (1.36 g, 0.01 mol) in 20 mL 1,4-dioxane, 10 mL of POCl3 was added 
portion wise with stirring at 0 C. The temperature was elevated gradually to 120 C and kept for 1h. After cooling the 
reaction mixture was poured onto ice/water mixture and the solid that separated  was filtered off and crystallized from 
EtOH to give 17. Yield 58 %; mp 185-186 °C; IR (KBr, cm
-1
): 1620 (C=N), 2986 (CH-aliph.), 3268 (NH); 
1
H-NMR (300 
MHz, DMSO-d6, δ / ppm): 2.13 (s, 3H, CH3), 3.54 (s, 2H, CH2), 6.54 (d, J=3.8Hz, 1H, furyl-H), 7.19-7.24 (m, 4H, Ar-H, 
pyrimidine-H & furyl-H), 7.58-7.65 (m, 4H, Ar-H & furyl-H), 7.86-8.09 (m, 2H, Ar-H). Anal. Calcd. for C24H16Cl2N4O2S 
(495.38): C, 58.19; H, 3.26; Cl, 14.31; N, 11.31; S, 6.47. Found: C, 58.38; H, 3.43; Cl, 13.89; N, 10.93; S, 6.09. 
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Formation of 18 and/or 19  
A mixture of 8 (3.95 g, 0.01 mol),  ethyl acetoacetate (0.70 g, 0.01 mol) and/or acetyl acetone (0.54 g, 0.01 mol), and few 
drops of piperidine in 30 mL EtOH was heated at 70 C for 6h. The solid that separated after concentration and cooling 
was filtered off and recrystallized from AcOH to give 2.27 g (49%) of 18 and 2.64 g (57%) of 19. 
2-({[4-(3,4-Dichlorophenyl)-6-(furan-2-yl)pyrimidin-2-yl]sulfanyl}acetyl)-5-methyl-2,4-
dihydro-3H-pyrazol-3-one (18): Yield 49%; mp 178-180 °C; IR (KBr, cm-1): 1611 (C=N), 1665 (CO), 2938 
(CH-aliph.); 
1
H-NMR (300 MHz, DMSO-d6, δ / ppm): 1.89 (3H, s, CH3), 3.40 (2H, s, CH2), 3.55 (2H, s, CH2), 6.53 (1H, dd, 
J1=1.7, J2=3.6, furyl-H), 7.03 (1H, s, pyrimidine-H), 7.20-7.26 (2H, m, Ar-H & furyl-H), 7.59-7.76 (3H, m, Ar-H & furyl-H). 
Anal. Calcd. for C20H14Cl2N4O3S (461.32): C, 52.07; H, 3.06; Cl, 15.37; N, 12.14; S, 6.95. Found: C, 52.32; H, 3.27; Cl, 
15.72; N, 12.35; S, 7.23. 
2-{[4-(3,4-Dichlorophenyl)-6-(furan-2-yl)pyrimidin-2-yl]sulfanyl}-1-(3,5-dimethyl 
pyrazolidin-1-yl)ethanone (19): Yield 57%; mp 142-144 °C; IR (KBr, cm-1): 1679 (CO), 2946 (CH-aliph.). Anal. 
Calcd. for C21H20Cl2N4O2S (463.38): C, 54.43; H, 4.35; Cl, 15.30; N, 12.09; S, 6.92. Found: C, 54.14; H, 4.52; Cl, 15.03; N, 
12.36; S, 7.18. 
 
RESULTS AND DISCUSSION 
The titled compound 4-(3,4-dichlorophenyl)-6-(furan-2-yl)pyrimidine-2-thiol (1) was prepared via base catalysed 
condensation of 3,4-dichloroacetophenone, furfural, and thiourea (one-pot, three components synthesis) or by 
condensation of furfurylidene-3,4-dichloroacetophenone with thiourea in the presence of MeONa as a catalyst. The 
reaction possibly takes place via Aza-Michael addition to the  unsaturated carbonyl moiety followed by cyclocondensation 
reaction to give the desired thioxopyrimidine 1. The reaction possibly takes place via the following mechanism, (Scheme 
1).  
CH3
O
Cl
Cl
OH
-
CH2
-
O
Cl
Cl
O
O
H
O
Cl
Cl
O
-
O
O
Cl
Cl
OH
O
O
Cl
Cl O
NH2 NH2
S
O
Cl
Cl O
NH
NH2
S
OH
Cl
Cl O
NH
NH2
S
N
Cl
Cl O
N
SH
H
+
H
+
OH2-
+
OH2-
-H2
(1)
 
Scheme 1. Reaction mechanism for compound 1 formation. 
The behaviour of thioxopyrimidine 1 towards nitrogen nucleophiles has been studied; its reaction with hydrazine hydrate 
was chosen as a model reaction, where the interaction of compound 1 with hydrazine hydrate in EtOH afforded 2 (Scheme 
2). The reaction takes place via nucleophilic attack at the electrophilic center at carbon of C=S group followed by loss of 
H2S molecule and aromatization to the desired product. When thioxopyrimidine 1 was submitted to react with ethylamine 
yielded 2-ethylaminopyrimidine 3. Condensation of thioxopyrimidine derivative 1 with piperidine in MeOH gave 2-
piperidinopyrimidine 4. Moreover, interaction of thioxopyrimidine 1 with 2-aminobenzoic acid has been investigated to 
proceed via refluxing a mixture of them in 1,4-dioxane followed by treatment with few drops of concentrated H2SO4 with 
continuous stirring at room temperature and resulted in the fused pyrimidino[2,3-b]quinazolinone 5 (Scheme 2). The IR 
spectrum of 5 revealed strong absorption band at 1660 cm
-1
 due to C=O and devoid any band for C=S and NH. The 
reaction possibly takes place via nucleophilic attack of amino group on electrophilic center (C=S) followed by acid 
catalysed dehydration to give the desired product. 
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Scheme 2. Behaviour of thioxopyrimidine 1 towards nitrogen and carbon nucleophiles. 
On the other hand, an understanding of the chemical behavior of thiopyrimidone 1 is of major importance in order to 
design the key starting material for production of many heterocyclic compounds with pharmecutical applications. The aim 
of this work is to determine the structures and mechanisms of the products obtained from the interaction of the 
thiopyrimidone with different carbon electrophiles. 
In all solvents, except petrol at high dilution, the 2- and 4-hydroxypyridines are extremely unfavoured in lactam-lactim 
dynamic equilibrium establishment [24]. Polar solvation effects strongly and favour the amide-like structure. In case of 2-
thioxopyrimidine, the strong -back bonding in the SH group perhaps it can be used to explain why some properties of 
thiol compounds are rather different than phenolic compounds. In this context, thioxopyrimidine 1 was allowed to react 
with chloroacetic acid in alcoholic NaOH and the 2-carboxythiomethoxy-pyrimidine 6 was furnished (Scheme 2). Solubility 
of compound 6 in aqueous solution of sodium bicarbonate is a good evidence for its formation. The reaction possibly takes 
place via nucleophilic attack of sulphur anion on the alkyl moiety of chloroacetic acid via SN2 mechanism, this presented 
as follows (Scheme 3). 
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Scheme 3. Mechanism for compound 6 formation. 
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Here the author offers a speculation to explain the activities of the thioamide and iminothiol equilibrium based on their 
thermodynamic and kinetic control under the experimental conditions. Firstly, in the presence of alcoholic NaOH the 
conjugate base of the iminothiol tautomer is more thermodynamically stable than conjugate base derived from thioamide 
tautomer via the -back donation involving the vacant d-orbital of the sulphur atom. Thereafter, the iminothiol tautomer is 
more predominate under such condition. Secondly, sulphur anion is strong nucleophilic than nitrogen anion (nucleophilicity 
is kinetic control). Thus, the iminothiol tautomer is more thermodynamically and kinetically favoured than thioamide 
tautomer, which practically spells out the reactivity of the iminothiol tautomer. 
Similarly, when 1 was submitted to react with ethyl chloroacetate in warming pyridine afforded 2-
ethoxycarbonylthiomethoxy-pyrimidine 7. The structure of compound 7 was proved chemically via its reaction with 
hydrazine hydrate and the 2-hydrazinocarbonylthiomethoxypyrimidine derivative 8 was obtained (Scheme 2). The reaction 
possibly takes place via tetrahedral mechanism involving lone pair of nitrogen and acyl moiety of ester group. In the 
present work, we wish to point out the interaction of thiopyrimidone derivative 1 with β-(4-bromobenzoyl and/or 2-
furyl)acrylic acid in the presence of piperidine as catalyst, The thia Michael adducts 9a,b were obtained (Scheme 2).  
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Scheme 4. Reactions with hydrazinopyrimidine 2. 
The chemistry of pyrimidines and thiopyrimidines have become in the last few years a subject of great interest, because 
they display some interesting properties in the field of organic chemistry [24,25]. In the present study, the authors have 
successful attempts to prepare hydrazinopyrimidine 2 as key starting material for synthesis some interesting nitrogen 
bridgehead compounds. Indeed, the hydrazino derivative 2 was allowed to react with Ac2O and the 2-methyl-1,3,4-
triazolo[1,5-b]pyrimidine 10 was afforded. Moreover, the hydrazino derivative 2 was submitted to react with CS2 in pyridine 
and resulted in 2-thioxo-1,3,4-trizolo[1,5-b]pyrimidine 11 (Scheme 4). Recently [26], it was reported that acid anhydrides 
reacted with 3-aminoquinazolinone derivatives and gave phthalimid 4(3H)-quinazolinone. In the present work we wish to 
point out the reaction of hydrazino derivative 2 with phthalic acid anhydride. Thus, when compound 2 was interacted with 
phthalic acid anhydride in an oil bath it yielded 2-phthalimidoamino-4-(2-furyl)-6-(3,4-dichlorophenyl)pyrimidine 12 
(Scheme 4). The reaction takes place via acylation of hydrazino moiety by phthalic acid anhydride followed by ring closure 
to give the desired product. 
More recently [27], it was reported that, hydrazide derivatives condensed with acetylacetone in boiling EtOH and yielded 
the corresponding pyrazole derivative. In the present work the author thought to investigate the behavior of the 
hydrazinopyrimidine derivative towards acetylacetone. Indeed, compound 2 was allowed to react with acetylacetone and 
the pyrimidine 13 was obtained (Scheme 4). 
Moreover, 2 was allowed to react with 4-hydroxybenzaldehyde in 1,4-dioxane and yielded the corresponding hydrazone 
14 (Scheme 4). The reaction takes place via nucleophilic attack of lone pair of nitrogen on the carbonyl group followed by 
dehydration to give the more thermodynamically hydrazone derivative. It is well known that the hydrazide moiety in 
pyridone derivative interacted with phenyl isothiocynate and gave hydrazinocarbothioamide derivatives [27]. This applies 
fully to hydrazino derivative 2 and yielded 2-phenylthiocarbamoylhydrazinopyrimidine 15 (Scheme 4). 
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Scheme 5. Reactions with hydrazinocarbonylthiomethoxypyrimidine 8. 
       On the other hand, interaction of the aminocarbamoyl derivative 8 with 4-chlorobenzaldehyde in EtOH afforded the 
corresponding hydrazone 16. The reaction possibly takes place via nucleophilic attack of lone pair of nitrogen on 
electrophilic carbon of aldehyde followed by lose of water molecule to give the more thermodynamically stable adduct 16. 
Interaction of P-toluic acid with 8 in the presence of POCl3 yielded the 2-[2-(4-methylphenyl)-1,3,4-oxadiazol-5-
yl]thiomethoxy-4-(2-furyl)-6-(3,4-dichlorophenyl)pyrimidine (17) (Scheme 5).  
When the hydrazide 8 was submitted to react with ethyl acetoacetate afforded 2-(3-methyl-5-oxo-pyrazolin-1-
yl)carbonylthiomethoxy-pyrimidine 18. The reaction takes place via interaction of lone pair of nitrogen atom with carbonyl 
moiety of ester [via nucleophilic addition to carbonyl group] followed by ring closure to give the desired product 18. The 
hydrazide derivative 8 interacted with acetylacetone yielded 2-[(3,5-dimethylpyrazol-1-yl)]carbonylthiomethoxy-pyrimidine 
19 (Scheme 5). 
CONCLUSION 
In summary, pyrimidine-2-thiol (1) has been successfully synthesized and utilized as building block of some heterocyclic 
systems as well as a novel series of thioxopyrimidine derivatives in excellent yield. 
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